BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12187168)

  • 1. Studying radiation therapy using SEER-Medicare-linked data.
    Virnig BA; Warren JL; Cooper GS; Klabunde CN; Schussler N; Freeman J
    Med Care; 2002 Aug; 40(8 Suppl):IV-49-54. PubMed ID: 12187168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of SEER-Medicare data for measuring cancer surgery.
    Cooper GS; Virnig B; Klabunde CN; Schussler N; Freeman J; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-43-8. PubMed ID: 12187167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
    Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
    Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the SEER-Medicare data to identify chemotherapy use.
    Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
    Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of Medicare claims data for measuring cancer stage.
    Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
    Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
    Gold HT; Do HT
    Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring complications of cancer treatment using the SEER-Medicare data.
    Potosky AL; Warren JL; Riedel ER; Klabunde CN; Earle CC; Begg CB
    Med Care; 2002 Aug; 40(8 Suppl):IV-62-8. PubMed ID: 12187170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
    Warren JL; Klabunde CN; Schrag D; Bach PB; Riley GF
    Med Care; 2002 Aug; 40(8 Suppl):IV-3-18. PubMed ID: 12187163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
    Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
    Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
    Lin CC; Virgo KS
    Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of Medicare claims data and cancer registries to identify cancer cases and treatment.
    McClish DK; Penberthy L; Whittemore M; Newschaffer C; Woolard D; Desch CE; Retchin S
    Am J Epidemiol; 1997 Feb; 145(3):227-33. PubMed ID: 9012595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of SEER Treatment Data With Medicare Claims.
    Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
    Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
    Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
    Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
    Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.
    Kent EE; Malinoff R; Rozjabek HM; Ambs A; Clauser SB; Topor MA; Yuan G; Burroughs J; Rodgers AB; DeMichele K
    J Am Geriatr Soc; 2016 Jan; 64(1):186-92. PubMed ID: 26782871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results.
    Du X; Freeman JL; Goodwin JS
    J Clin Epidemiol; 1999 May; 52(5):463-70. PubMed ID: 10360342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.
    Engels EA; Pfeiffer RM; Ricker W; Wheeler W; Parsons R; Warren JL
    Am J Epidemiol; 2011 Oct; 174(7):860-70. PubMed ID: 21821540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources.
    Schrag D; Bach PB; Dahlman C; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-96-103. PubMed ID: 12187174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
    Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
    J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.